Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK. [electronic resource]
Publication details: PharmacoEconomics - open Mar 2017Description: 25-36 p. digitalISSN:- 2509-4254
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.